Aileron Therapeutics, Inc.
ALRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $6 | $7 | $13 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $5 | $7 | $8 | $14 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $6 | $6 | $6 | $6 |
| Intangibles | $42 | $42 | $42 | $42 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $1 | $0 |
| Total NC Assets | $49 | $51 | $49 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $54 | $57 | $58 | $62 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $5 | $5 |
| Total Curr. Liab. | $6 | $8 | $6 | $6 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $2 | $2 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8 | $9 | $8 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $45 | $45 | $45 | $45 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$369 | -$364 | -$357 | -$351 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $415 | $412 | $407 | $406 |
| Total Equity | $46 | $48 | $50 | $54 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $54 | $57 | $58 | $62 |
| Net Debt | -$4 | -$6 | -$7 | -$13 |